Monthly testing with isotretinoin might be unnecessary
But evidence-based guidelines needed to support clinicians in any change in practiceRelated items from OnMedicaAcne drug linked to inflammatory bowel diseaseExperts call for research on acne treatmentsAttempted suicide risk increases with severe acne (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 3, 2015 Category: UK Health Source Type: news
Medical News Today: Isotreninoin: are the lab tests really necessary?
A meta-analysis suggests that the regular lab tests for people taking isotretinoin may not be necessary, as few of the tests indicate side effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 2, 2015 Category: Consumer Health News Tags: Dermatology Source Type: news
Decrease in "Hamilton Rating Scale for Depression" following isotretinoin therapy in acne: an open-label prospective study - Gnanaraj P, Karthikeyan S, Narasimhan M, Rajagopalan V.
BACKGROUND: Acne is a common disorder among adolescents and young adults causing a considerable psychological impact including anxiety and depression. Isotretinoin, a synthetic oral retinoid is very effective in the treatment of moderate to severe acne. Bu... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 8, 2015 Category: Global & Universal Tags: Age: Adolescents Source Type: news
Acne: Antibiotic Use Regularly Exceeds Recommended DurationAcne: Antibiotic Use Regularly Exceeds Recommended Duration
Despite guidelines limiting recommended antibiotic use to 3 months, patients took them for an average 11 months before starting isotretinoin therapy, a new study showed. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2015 Category: Consumer Health News Tags: Dermatology News Source Type: news
Treating severe acne hampered by 'antibiotic overuse'
Clinicians treating severe acne leave too many patients on ineffective antibiotics for far too long before prescribing more potent needed therapy with isotretinoin, claim US researchers. (Source: Nursing Times Breaking News)
Source: Nursing Times Breaking News - October 30, 2015 Category: Nursing Source Type: news
Treatment of severe acne hampered by antibiotic overuse, delays in prescribing more potent medication
Physicians who treat severe acne leave too many patients on ineffective antibiotics for far too long before prescribing more potent needed therapy with the medication isotretinoin, sometimes known by its former brand name Accutane, a medical records analysis concludes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 30, 2015 Category: Science Source Type: news
Treatment of severe acne hampered by antibiotic overuse and delays in prescribing more potent medication
(NYU Langone Medical Center / New York University School of Medicine) A medical records analysis by researchers at NYU Langone Medical Center concludes that physicians who treat severe acne leave too many patients on ineffective antibiotics for far too long before prescribing more potent needed therapy with the medication isotretinoin, sometimes known by its former brand name Accutane. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 30, 2015 Category: Global & Universal Source Type: news
Inter-relationships between isotretinoin treatment and psychiatric disorders: depression, bipolar disorder, anxiety, psychosis and suicide risks - Ludot M, Mouchabac S, Ferreri F.
Isotretinoin (Accutane) is a treatment for severe acne that is resistant to other forms of treatment, including antibiotics and topical treatments. The prescription of this drug has been controversial ever since its initial marketing in 1982. It is the onl... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - July 4, 2015 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news
Using Lessons From an Underserved Family Medicine Dermatology Fellowship to Improve Family Medicine Resident Learning in Dermatology (Richard Usatine MD)
The first half of the session will describe the only underserved family medicine dermatology fellowship in the country. The second half will apply ideas from the fellowship training to the training of family medicine residents in dermatology. One of the stated goals of the fellowship is to improve the quality of dermatology training across the board for family physicians. The faculty and fellows in the program have been instrumental in developing new resources and curricula in dermatology. These resources will be shared with the participants. Some of the special skills learned in the fellowship that could be taught to fami...
Source: Family Medicine Digital Resources Library (FMDRL) Recently Uploaded - April 26, 2015 Category: Primary Care Source Type: news
Cipher Pharmaceuticals announces outcome of Markman hearing in patent infringement suit for Absorica(R)
MISSISSAUGA, ON, April 24, 2015 -- (Healthcare Sales & Marketing Network) - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that the Court has issued an opinion in the claim construction h... Biopharmaceuticals, Generics, LitigationCipher Pharmaceuticals, Ranbaxy, Sun Pharma Company, Absorica, isotretinoin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2015 Category: Pharmaceuticals Source Type: news
ASK THE DOCTOR: Can drugs to clear up spots make you depressed?
Dr Scurr says the greatest cause for concern is the psychiatric effects of oral isotretinoin. 'It is uncertain whether there is a relationship between the depression and suicidal behaviour.' (Source: the Mail online | Health)
Source: the Mail online | Health - March 31, 2015 Category: Consumer Health News Source Type: news
DHMA monitoring isotretinoin use
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2015 Category: Drugs & Pharmacology Source Type: news
isotretinoin, Claravis, Amnesteem, Absorbica, Myorisan, Zenatane
Title: isotretinoin, Claravis, Amnesteem, Absorbica, Myorisan, ZenataneCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/25/2015 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - February 25, 2015 Category: Dermatology Source Type: news
isotretinoin, Claravis, Amnesteem, Absorbica, Myorisan, Zenatane
Title: isotretinoin, Claravis, Amnesteem, Absorbica, Myorisan, ZenataneCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/25/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 25, 2015 Category: Drugs & Pharmacology Source Type: news
isotretinoin, Claravis, Amnesteem, Absorica, Myorisan, Zenatane
Title: isotretinoin, Claravis, Amnesteem, Absorica, Myorisan, ZenataneCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/25/2015 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - February 25, 2015 Category: Dermatology Source Type: news
